Evaluation of human papillomavirus infection in women in the Lipetsk Region, by using a diagnostic self-sampling test
- Authors: Apolikhina I.A.1,2, Bashirova L.K.2, Letnikova L.I.3, Khudyakova O.V.3, Ivanov S.A.3, Gorbunova E.A.1, Dolgushina N.V.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
- Healthcare Department of the Lipetsk Region
- Issue: No 11 (2018)
- Pages: 98-104
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248339
- DOI: https://doi.org/10.18565/aig.2018.11.98-104
- ID: 248339
Cite item
Abstract
Full Text
About the authors
Inna A. Apolikhina
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: i_apolikhina@oparina4.ru
MD, head of the Department of Aesthetic Gynecology and Rehabilitation; Professor of the Department of Obstetrics, Gynecology and Perinatology
Lala K. Bashirova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: leyla9296@hotmail.com
competitor of a scientific degree of candidate of science
Lyudmila I. Letnikova
Healthcare Department of the Lipetsk Regiondeputy head of administration of the Lipetsk region
Olga V. Khudyakova
Healthcare Department of the Lipetsk Regionconsultant of the department of organization of medical care for children and the obstetric aid service of the health department of the Lipetsk region
Sergey A. Ivanov
Healthcare Department of the Lipetsk Regionhead of the department of organization of medical care for children and the obstetric aid service of the health department of the Lipetsk region
Elena A. Gorbunova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russiaobstetrician-gynecologist, physiotherapist of the Department of Aesthetic Gynecology and Rehabilitation
Natalia V. Dolgushina
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of RussiaMD, head of the department of scientific planning and audit
References
- Левшин В.Ф., Завельская А.Я. Факторы риска и профилактика рака шейки матки. Вопросы онкологии. 2017; 63(3): 506-16.
- Crossley B., Crossley J. A review of the use of human papilloma virus (HPV) in cervical screening. Br. J. Btomed. Sci. 2017; 74(3): 105-9.
- Cummings M.C., Marquart L., Pelecanos A.M., Perkins G., Papadimos D., O’Rourke P. et al. Which are тоге correctly diagnosed: conventional Papanicolaou smears ог Thinprep samples? A comparative study of 9 years of external quality-assurance testing. Cancer Cytopathol. 2015; 123(2): 108-16.
- Tjalma W.A. The ideal cervical cancer screening recommendation Гог Belgium, an industrialized country in Europe. Eur. J. Gynaecol. Oncol. 2014; 35(3): 211-8.
- Ronco G., Dillner J., Elfström K.M., Tunesi S., Snijders P.J., Arbyn M. et al. Efficacy of HPV-based screening Гог prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014; 383(9916): 524-32.
- Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J. et al. American Cancer Society, American Society Гог Colposcopy and Cervical Pathology, and American Society Гог Clinical Pathology screening guidelines Гог the prevention and early detection of cervical cancer. Am. J. Clin. Pathol. 2012; 137(4): 516-42.
- Zhou H., Mody R.R., Luna E., Armylagos D., Xu J., Schwartz M.R. et al. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test Гог the detection of high-grade cervicovaginal lesions. Cancer Cytopathol. 2016; 124(5): 317-23.
- Benevolo M., Allia E., Gustinucci D., Rollo F., Bulletti S., Cesarini E. et al. Interobserver reproducibility of cytologic p16INK4a/Ki-67 dual immunostaining in human papillomavirus positive women. Cancer Cytopathol. 2017; 125(3): 212-20.
- Uijterwaal M.H., Polman N.J., Witte B.I., van Kemenade F.J., Rijkaart D., Berkhof J. et al. Triaging HPV-positive women with normal cytology by p16/ Ki-67 dual-stained cytology testing: baseline and longitudinal data. Int. J. Cancer. 2015; 136(10): 2361-8.
- Koeneman M.M., Kruitwagen R.F., Nijman H.W., Slangen B.F., Van Gorp T., Kruse A.J. Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers. Expert Rev. Mol. Diagn. 2015; 15(4): 527-46.
- Ebisch R.M., Siebers A.G., Bosgraaf R.P., Massuger L.F., Bekkers R.L., Melchers WJ. Triage of high-risk HPV positive women in cervical cancer screening. Expert Rev. Anticancer Ther. 2016; 16(10): 1073-85.
- Arbyn M., Verdoodt F., Snijders P.J., Verhoef V.M., Suonio E., Dillner L. et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014; 15(2): 172-83.
- Chen K., Ouyang Y., Hillemanns P., Jentschke M. Excellent analytical and clinical performance of a dry self-sampling device Гог human papillomavirus detection in an urban Chinese referral population. J. Obstet. Gynaecol. Res. 2016; 42(12): 1839-45.
- Tamalet C., Le Retraite L., Leandri F.X., Heid P., Garnier H.S., Piana L. Vaginal selEsampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening. Clin. Microbiol. Infect. 2013; 19(1): 44-50.
- Dijkstra M.G., Heideman D.A., van Kemenade F.J., Hogewoning K.J., Hesselink A.T., Verkuijten M.C. et al. Brush-based selfsampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes Гог HPV genotyping and detection of high-grade CIN. J. Clin. Virol. 2012; 54(2): 147-51.
- Arrossi S., Ramos S., Straw C., Thouyaret L., Orellana L. HPV testing: a mixed-method approach to understand why women prefer selEcollection in a middle-income country. BMC Public Health. 2016; 16: 832.
- Bosch F.X., Broker T.R., Forman D., Moscicki A.B., Gillison M.L., Doorbar J. et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2012; 31(Suppl. 7): H1-31.
- Белокриницкая Т.Е., Фролова Н.И., Тарбаева Д.А., Глотова Е.Ю., Золотарёва А.А., Мальцева Т.В. Конфаундинг-факторы папилломавирусной инфекции и цервикальной дисплазии у молодых женщин. Доктор.Ру. 2015; 14: 7-11.
- Zehbe I., Jackson R., Wood B., Weaver B., Escott N., Severini A. et al. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology. BMJ Open. 2016; 6(10): e011754.
- Ortiz A.P., Alejandro N., Pérez, C.M., Otero Y., Soto-Salgado M., Palefsky J.M. et al. Acceptability of Cervical and Anal HPV Self-sampling in a sample of Hispanic women in Puerto Rico. P. R. Health Sci. J. 2012; 31(4): 205-12.
- Darlin L., Borgfeldt C., Forslund O., Hénic E., Hortlund M., Dillner J. et al. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening. J. Clin. Virol. 2013; 58(1): 155-60.
- Verdoodt F., Jentschke M., Hillemanns P., Racey C.S., Snijders P.J., Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur. J. Cancer. 2015: 51(16): 2375-85.
- Аполихина И.А., Филиппенкова Е.В., Додова Е.Г., Гасанова Г.Ф., Горбунова Е.А. Современные возможности организованного скрининга рака шейки матки. Акушерство и гинекология. 2016; 9: 12-8.
- Белокриницкая Т.Е., Фролова Н.И., Туранова О.В., Шемякина К.Н., Плетнева В.А., Самбуева Н.Б., Мальцева Е.Е. Результативность и приемлемость обследования на вирус папилломы человека при самостоятельном и врачебном заборе вагинального отделяемого. Акушерство и гинекология. 2017; 2: 97-105.